Table 1.
Demographic characteristics of screened patients
| Variable (n = 255) | n (%) |
|---|---|
|
| |
| Screened and enrolled | 111 (43.5) |
| Screened: TBTC Site 33, Cape Town, South Africa (% of total screened) | 111 (43.5) |
| Enrolled (% of screened at site) | 48 (43.2) |
| Screened: TBTC Site 38, Lima, Peru (% of total screened) | 56 (21.9) |
| Enrolled (% of screened at site) | 24 (42.9) |
| Screened: TBTC Site 99, Lima, Peru (% of total screened) | 88 (34.5) |
| Enrolled (% of screened at site) | 39 (44.3) |
| Country: Peru | 144 (56.5) |
| Male sex | 164 (63.9) |
| Age, years, median [IQR] | 31 [22–43] |
| History of previous TB | 104 (40.8) |
| No history of TB | 151 (59.2) |
| Cure/completion | 72 (28.2) |
| Negative previous treatment outcome | 32 (12.6) |
| Treatment failure | 4(1.6) |
| Failed to adhere | 17 (6.6) |
| Other | 11 (4.3) |
| BMI, kg/m2, median [IQR] | 20.6 [18.5–23.3] |
| Karnofsky score ≤80 | 106 (41.6) |
| Homelessness* | 7 (2.8) |
| Unemployment* | 92 (36.4) |
| Non-IV drug use* | 29 (11.5) |
| IV drug use* | 0 |
| Smoker* | 114 (45.1) |
| Diabetes | 12 (4.7) |
| HIV* | 60 (23.8) |
| CD4 count among HIV positive, cells/mm3, median [IQR] | 196 [92–366] |
*
Missing data: homelessness (n = 2), unemployment (n = 2), non-IV drug use (n = 2), IV drug use (n = 2), smoker (n = 2), HIV (n = 3).
TBTC = Tuberculosis Trials Consortium; IQR = interquartile range; BMI = body mass index; IV = intravenous.